Al-Modawat Specialized Medical Co. (9594.SR) — Financial statements
Income statement, balance sheet, and cash flow for Al-Modawat Specialized Medical Co. — annual and quarterly history with growth and margin analysis.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 122↑61.4% | 75↑1.6% | 74↑26.9% | 59↑43.4% | 41 | |
| Cost of Revenue | 69↑49.7% | 46↑36.4% | 34↑9.8% | 31↑14.4% | 27 | |
| Gross Profit | 53↑79.5% | 30↓27.3% | 41↑45.7% | 28↑98.8% | 14 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 23↑663.5% | 3↑62.8% | 2↓87.9% | 16 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 0.16↑105.0% | 0.08↑112.3% | -0.64 | |
| SG&A Expenses | 0.00↓100.0% | 23↑625.7% | 3↓78.6% | 15↑1.1% | 15 | |
| Other Expenses | 31↑1973.4% | -2↓110.5% | 16↑1058.3% | 1 | 0.00 | |
| Operating Expenses | 31↑42.1% | 22↑14.8% | 19↑15.4% | 16↑10.2% | 15 | |
| Total Costs & Expenses | 100↑47.3% | 68↑25.1% | 54↑14.9% | 47↑12.9% | 42 | |
| Operating Results | ||||||
| Operating Income | 22↑184.6% | 8↓61.6% | 20↑76.2% | 11↑1380.3% | -0.89 | |
| Depreciation & Amortization | 0.00 | 0.00↓100.0% | 2↓17.0% | 2↑9.4% | 2 | |
| EBITDA | 22↑171.1% | 8↓60.9% | 21↑54.9% | 13↑962.2% | 1 | |
| EBIT | 22↑171.1% | 8↓60.9% | 21↑83.7% | 11↑1816.7% | -0.66 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -1↑1.0% | -1↓90.7% | -0.69↓1870.5% | -0.04 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 1↓1.0% | 1↑90.7% | 0.69↑1870.5% | 0.04 | |
| Non-Operating Income | 0.00↑100.0% | -0.57↑5.8% | -0.60↓530.9% | 0.14↑159.3% | -0.24 | |
| Other Income / Expenses | -22↓2209.3% | -0.95↓32.2% | -0.72↑13.3% | -0.83↓516.2% | 0.20 | |
| Income Before Tax | 0.00↓100.0% | 7↓65.1% | 19↑83.3% | 11↑1629.6% | -0.69 | |
| Income Tax Expense | 0.00↓100.0% | 0.72↓15.9% | 0.85↑187.7% | 0.30↓80.4% | 2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 0.00↓100.0% | 6↓67.3% | 19↑80.3% | 10↑567.4% | -2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 19↑212.4% | 6↓67.3% | 19↑80.3% | 10↑567.4% | -2 | |
| Bottom-Line Net Income | 19↑212.4% | 6↓67.3% | 19↑80.3% | 10↑567.4% | -2 | |
| EPS (Basic) | 0.27↑3.8% | 0.26↓66.7% | 0.78↑81.4% | 0.43↑562.9% | -0.09 | |
| EPS (Diluted) | 0.27↑3.8% | 0.26↓66.7% | 0.78↑81.4% | 0.43↑562.9% | -0.09 | |
| Weighted Average Shares | 70↑200.9% | 23↓1.6% | 24↑0.0% | 24↑0.0% | 24 | |
| Weighted Average Diluted Shares | 70↑200.9% | 23↓1.6% | 24↑0.0% | 24↑0.0% | 24 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.